Page last updated: 2024-11-07

spironolactone and Right Ventricular Dysfunction

spironolactone has been researched along with Right Ventricular Dysfunction in 3 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
"Patients with SRV treated with eplerenone showed an improvement of an altered baseline CTB profile suggesting that reduction of myocardial fibrosis might be a therapeutic target in these patients."5.17Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study. ( Casaldàliga, J; Dos, L; Estruch, M; Ferreira-González, I; García-Dorado, D; Marsal, JR; Mas, A; Ordóñez-Llanos, J; Pijuan, A; Pons-Lladó, G; Pujadas, S; Serra, R; Subirana, M, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dos, L1
Pujadas, S1
Estruch, M1
Mas, A1
Ferreira-González, I1
Pijuan, A1
Serra, R1
Ordóñez-Llanos, J1
Subirana, M1
Pons-Lladó, G1
Marsal, JR1
García-Dorado, D1
Casaldàliga, J1
Borgdorff, MA1
Bartelds, B1
Dickinson, MG1
Steendijk, P1
Berger, RM1
Bansal, S1
Badesch, D1
Bull, T1
Schrier, RW1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Aldosterone Antagonists in Systemic Right Ventricle: a Randomized Clinical Trial.[NCT00703352]Phase 426 participants (Actual)Interventional2008-07-31Completed
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function - a Multi-center, Double-blind, Randomized, Placebo-controlled Clinical Trial - SERVE Trial[NCT03049540]Phase 3100 participants (Actual)Interventional2017-10-25Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for spironolactone and Right Ventricular Dysfunction

ArticleYear
Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
    International journal of cardiology, 2013, Oct-15, Volume: 168, Issue:6

    Topics: Adult; Aldosterone; Cardiac Imaging Techniques; Collagen; Double-Blind Method; Eplerenone; Female; F

2013
Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
    International journal of cardiology, 2013, Oct-15, Volume: 168, Issue:6

    Topics: Adult; Aldosterone; Cardiac Imaging Techniques; Collagen; Double-Blind Method; Eplerenone; Female; F

2013
Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
    International journal of cardiology, 2013, Oct-15, Volume: 168, Issue:6

    Topics: Adult; Aldosterone; Cardiac Imaging Techniques; Collagen; Double-Blind Method; Eplerenone; Female; F

2013
Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.
    International journal of cardiology, 2013, Oct-15, Volume: 168, Issue:6

    Topics: Adult; Aldosterone; Cardiac Imaging Techniques; Collagen; Double-Blind Method; Eplerenone; Female; F

2013
Role of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.
    Contemporary clinical trials, 2009, Volume: 30, Issue:5

    Topics: Aldosterone; Health Status Indicators; Humans; Hypertension, Pulmonary; Mineralocorticoid Receptor A

2009

Other Studies

1 other study available for spironolactone and Right Ventricular Dysfunction

ArticleYear
A cornerstone of heart failure treatment is not effective in experimental right ventricular failure.
    International journal of cardiology, 2013, Nov-05, Volume: 169, Issue:3

    Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Failure; Losartan; Mal

2013